ARCHIVES

Approval Granted For New Formulation of Lupron Depot

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006